NewsBite

Healthcare

Yesterday

Telix co-founder and CEO Christian Behrenbruch.

Telix subpoenaed by US regulator over cancer therapy

The Melbourne-based biotech says it has notified ASIC about the investigation by US regulators.

Hayden Brass

How an introvert’s brand raked in $8m in sales

Hayden Brass knew his humble family business could be more. Now the founder of health and wellness company Zea is a 2025 BOSS Young Executive.

This Month

Mayne Pharma sells products in Australia and the US for birth control and menopause treatments.

Jefferies, Mayne Pharma in spotlight after suitor’s court win

US medicines giant Cosette has successfully sought confidential modelling that it says could prove it was given incomplete financial information.

.

Mesoblast shares soar 35pc on strong cell therapy sales data

The biotech says sales of its first commercial therapy, Ryoncil, were $20 million in the quarter ending June 30.

Mark De Ambrosis is co-founder and managing director of Armitage Associates.

Armitage readies healthtech for sale, tapping Houlihan Lokey

Mark De Ambrosis’ Armitage first bought into MYP in December 2020, acquiring a stake just north of 50 per cent.

Advertisement
.

Waiting to get rich from biotech? Don’t hold your breath

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in the rough.

Pro Medicus co-founders Anthony Hall and Sam Hupert.

The 10 wealthiest executives in the ASX 300 revealed

Healthcare and tech company bosses, including the co-founders of the ASX’s newest $30 billion company Pro Medicus, dominate the Rich Bosses list.

Healthscope chief executive Tino La Spina is pitching a plan which will see the hospital operator bid for itself.

Healthscope’s not-for-profit plan to bid for itself

Healthscope’s lenders are weighing up a proposal to restructure the hospital operator into a not-for-profit company which will save $100 million on payroll tax.

Riverside’s Simon Feiglin says private equity needs to tell its stories better.

AI is giving private equity a new headache

The local boss of US private equity group Riverside Company says a kid can use AI to replicate a company’s software in hours. That’s a big new risk to price in.

Peter Scutt - Co-founder and CEO Mable.

New tech deal alert: General Atlantic hires advisers to sell $1b Mable

Mable, a marketplace platform that works with NDIS participants and at-home carers, was founded in 2014 by Peter Scutt and Tony Charara.

Stop the mental health blowout, says Labor MP

Paediatrician and MP Mike Freelander says the way society diagnoses mental health is part of the problem behind a huge rise in compensation claims.

CSL chief executive Paul McKenzie will outline plans to cut the company’s R&D spend at the company’s full-year results next month.

CSL prepares to slash R&D as it grapples with looming Trump tariffs

The market is focused on a mooted 200 per cent levy on the pharmaceutical giant’s goods. There are far more significant changes afoot at the company.

While many Australians are complaining about the cost of their health insurance, some funds are offering 12 weeks free membership for new customers.

Health insurer promotion frenzy draws federal government scrutiny

Dozens of funds are offering free cover for up to three months, saving members thousands of dollars if they sign up. Worries about how they work are growing.

Donald Trump’s tariff on pharmaceutical products would affect more than $2 billion in Australian exports, largely made up of CSL’s goods manufactured in Melbourne.

Target hostile countries, not us, drug giant CSL tells Trump

The country’s biggest pharmaceuticals group pointed to “specific non-allied countries” and urged the White House to reconsider a 200 per cent tariff.

No gaps: Is this the future of private hospitals?

A combination of doctors’ frustration, an available site and a developer looking to expand led to the building of a $100 million hospital.

Advertisement
Healthscope chief executive Tino La Spina says the operator as a future once it sorts out its debt and high rents.

Healthscope’s problems are huge, Tino La Spina says he can fix it

While the company’s receivers are being pressured to break up the hospital group, there is also an alternative vision to keep it whole.

Chemist Warehouse founders like Mario Verrochi and Jack Gance

The pharmacists who made millions from Chemist Warehouse’s IPO

The retailer’s co-founders are well-known billionaires, but its backdoor listing with Sigma made hundreds of its store managers multimillionaires overnight.

Greg Hunt says more public patients using private hospital beds will alleviate record waiting lists.

Greg Hunt says states should pay private hospitals for public beds

The former health minister is now a senior adviser at Alvarez & Marsal. He says public funding could help the struggling sector and cut down waiting lists.

Artificial intelligence is being used to detect patterns among infected contacts.

Microsoft claims AI diagnostic tool can outperform doctors

The new system is underpinned by a so-called “orchestrator” that creates virtual panels of five AI agents acting as “doctors”, each with a distinct role.

June

Double act: I-MED chief executive Shrey Viranna and his chairman, George Savvides, oversee one of the biggest privately owned health businesses in Australia.

Permira’s radiology giant I-MED signs $1.8b refi; eight banks pile in

I-MED has been negotiating a $3b sale to Mike Dorrell’s Stonepeak Infrastructure Partners since at least March – however  these talks have since cooled.

Original URL: https://www.afr.com/topic/healthcare-5y6